Renal artery embolisation in the palliative treatment of renal carcinoma

British Journal of Radiology

Volumn 80, Issue 950, 2007, Pages 96-102

  Maxwell, N J ^a,b   Amer, N Saleem ^a   Rogers, E ^a   Kiely, D ^a   Sweeney, P ^a   Brady, A P ^a  

^a MERCY UNIVERSITY HOSPITAL   (Ireland)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; HEMOGLOBIN; METAL; POLYVINYL ALCOHOL;

ADULT; AGED; ARTIFICIAL EMBOLISM; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; COIL EMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; FLANK PAIN; HEMATURIA; HOSPITAL DISCHARGE; HUMAN; INOPERABLE CANCER; KIDNEY CARCINOMA; LENGTH OF STAY; MALE; MEDICAL DECISION MAKING; MORBIDITY; NEPHRECTOMY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT SAFETY; PROSTATE BIOPSY; RENOGRAPHY; REVIEW; SYMPTOM; ARTICLE; EVALUATION; KIDNEY TUMOR; METHODOLOGY; MIDDLE AGED; PALLIATIVE THERAPY; RENAL ARTERY; SURVIVAL; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; KIDNEY NEOPLASMS; LENGTH OF STAY; MALE; MIDDLE AGED; PALLIATIVE CARE; RENAL ARTERY; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 34250219959     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/31311739     Document Type: Review

References (26)

1. Parker S, Tong T, Bolden S, Wingo PA. Cancer statistics, 1996. Cancer J Clin 1996;46:5-27.
2. Stenzel A, deKernion JB. Pathology, biology, and clinical staging of renal cell carcinoma. Sem Oncol (Suppl.) 1989;16:3-11.
3. Ritchie AW, deKernion JB. The natural history and clinical features of renal carcinoma. Semin Nephrol 1987;7:131-9.
4. deKernion JB, Ramming KP, Smith RB. The natural history of metastatic renal cell carcinoma: a computer analysis. J Urol 1978;120:148-52.
5. Mahnken AH, Rohde D, Brkovic D, Gunther RW, Tacke JA. Percutaneous radiofrequency ablation of renal cell carcinoma - preliminary results. Acta Radiol 2005;46:208-14.
6. Marberger M, Schatzl G, Cranston D, Kennedy JE. Extracorporeal ablation of renal tumours with high-intensity focused ultrasound. BJU Int 2005;95(Suppl. 2):52-5.
7. Mickisch GH, Garin A, van Poppel H, de Prijck L, Sylvester R. European Organisation for Research and Treatment of Cancer (EORTC). Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal cell carcinoma: a randomized trial. Lancet 2001;358:966-70.
8. Flanigan RC, Salmon SE, Blumenstein BA, Bearman SI, Roy V, McGrath PC, et al. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal cell cancer. N Engl J Med 2001;345: 1655-9.
9. Motzer RJ, Russo P. Systemic therapy for renal cell carcinoma. J Urol 2000;163:408-17.
10. Lalli AF, Peterson N, Bookstein JJ. Roentgen-guided infarctions of kidney and lungs: a potential therapeutic technique. Radiology 1969,93:434-5.
11. Kaisary AV, Williams G, Riddle PR. The role of preoperative embolization in renal cell carcinoma. J Urol 1984;131:641-6.
12. Nakano H, Nihira H, Toge T. Treatment of renal cancer patients by transcatheter embolization and its effects on lymphocyte proliferative responses. J Urol 1983;130:24-7.
13. Nurmi M, Satokari K, Puntala P. Renal artery embolization in the palliative treatment of renal adencarcinoma. Scand J Urol Nephrol 1987;21:93-6.
14. Park JH, Kim SH, Han JK, Chung JW, Han MC. Transcatheter arterial embolization of unresectable renal cell carcinoma with a mixture of ethanol and iodised oil. Cardiovasc Intervent Radiol 1994;17:323-7.
15. Flanigan RC, Mickisch G, Sylvester R, Tangan C, van Poppel H, Crawford ED. Cytoreductive nephrectomy in patients with metastatic renal cancer: A combined analysis. J Urol 2004;171:1071-6.
16. Lanigan D, Jurriaans E, Hammonds JC, Wells IP, Choa RG. The current status of embolization in renal cell carcinoma - a survey of local and national practice. Clin Radiol 1992;46:176-8.
17. Christensen K, Dyreborg U, Andersen JF, Nissen HM. The value of transvascular embolization in the treatment of renal carcinoma. J Urol 1985;133:191-3.
18. Flanigan RC. The failure of infarction and/or nephrectomy in stage IV renal cell cancer to influence survival or metastatic regression. Urol Clin North Am 1987;14:757-62.
19. Bendszus M, Klein R, Burger R, Warmuth-Metz M, Hofmann E, Solymosi L. Efficacy of trisacryl gelatin microspheres versus polyvinyl alcohol particles in the preoperative embolization of meningiomas. Am J Neuroradio 2000;21:255-61.
20. Derdeyn C, Graves V, Salamat M, Rappe A. Collagen-coated acrylic microspheres for embolotherapy: in vivo and in vitro characteristics. Am J Neuroradiol 1997;18(4):647-53.
21. Munro NP, Woodhams S, Nawrocki JD, Fletcher MS, Thomas PJ. The role of transarterial embolization in the treatment of renal cell carcinoma. BJU Int 2003;92:240-4.
22. Bono AV, Caresano A. The role of embolization in the treatment of kidney carcinoma. Eur Urol 1983;9:334-7.
23. Tigrani VS, Reese DM, Small EJ, Presti JC, Carroll PR. Potential role of nephrectomy in the treatment of metastatic renal cell carcinoma: A retrospective analysis. Urology 2000;55:36-40.
24. Onishi T, Oishi Y, Suzuki Y, Asano K. Prognostic evaluation of transcatheter arterial embolization for unresectable renal cell carcinoma with distant metastases. BJU Int 2001;87:312-5.
25. Marx FJ, Chaussy C, Moser E. Grenzea and gefahren der palliativen embolization inoperable nierentumoren. Urologe A 1982;21:206-10.
26. Wallace S, Chuang VP, Swanson D, Bracken B, Hersh EM, Ayala A, et al. Embolization of renal carcinoma. Radiology 1981;138:563-70.